Floatz logo

Nerandomilast

Progressive Pulmonary Fibrosis

Boehringer IngelheimSmall moleculePhase 3Active
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
95/ 100

Competitive context

15 Active assets in the Progressive Pulmonary Fibrosis cohort.

Asset / SponsorPhaseRating
N-Acetyl-L-Cysteine
Boehringer Ingelheim
Phase 3BB
Nintedanib
Boehringer Ingelheim
Phase 3BB
Pirfenidone
Boehringer Ingelheim
Phase 2BB
Admilparant
Bristol-Myers Squibb
Phase 3BB
Sildenafil
Alicia Gerke
Phase 3BB

View all 38 →

Same molecule, other indications

Nerandomilast is also rated in:

idiopathic pulmonary fibrosisDormant
BB
Indicative ·
66 / 100
View asset →
amyotrophic lateral sclerosisDormant
CCC
Indicative ·
55 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →